• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白在影响小肠和结肠的克罗恩病中敏感性相同。

Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.

作者信息

Jensen Michael Dam, Kjeldsen Jens, Nathan Torben

机构信息

Department of Internal Medicine, Section of Gastroenterology, Lillebaelt Hospital Vejle, Vejle, Denmark.

出版信息

Scand J Gastroenterol. 2011 Jun;46(6):694-700. doi: 10.3109/00365521.2011.560680. Epub 2011 Apr 1.

DOI:10.3109/00365521.2011.560680
PMID:21456899
Abstract

OBJECTIVE

The utility of fecal calprotectin (fCal) in small bowel Crohn's disease (CD) remains to be clarified. The primary aim of this study was to determine levels of fCal in CD restricted to the small bowel compared with CD affecting the colon, in patients undergoing their first diagnostic work-up. In addition, the study assessed the sensitivity and specificity of fCal in suspected CD.

MATERIAL AND METHODS

A total of 83 patients referred to gastroenterology out-patient clinic with suspected CD were included in this prospective, blinded study, and fCal was measured during diagnostic work-up. Ileo-colonoscopy + capsule endoscopy/surgery (n = 81), ileo-colonoscopy + upper endoscopy (n = 1), and ileo-colonoscopy (n = 1) served as gold standard for the presence and location of CD.

RESULTS

A total of 40 patients were diagnosed with CD: small bowel 13, colonic 16, and ileo-colonic 11. Levels of fCal were equal in patients with small bowel or colonic CD: median 890 mg/kg and 830 mg/kg, respectively (p = 1.0). With a 50 mg/kg cut-off, CD in the small intestine and colon was diagnosed with 92% and 94% sensitivities, respectively, and the overall sensitivity and specificity of fCal was 95% and 56%. In this cohort, CD was ruled out with a negative predictive value of 92%.

CONCLUSIONS

This is the first study to show that fCal is equally sensitive in colonic and small bowel CD. In patients suspected of CD, fCal is an effective marker to rule out this diagnosis and select patients for endoscopy.

摘要

目的

粪便钙卫蛋白(fCal)在小肠克罗恩病(CD)中的作用仍有待阐明。本研究的主要目的是确定在首次接受诊断检查的患者中,局限于小肠的CD患者与累及结肠的CD患者的fCal水平。此外,本研究评估了fCal在疑似CD中的敏感性和特异性。

材料与方法

本前瞻性、盲法研究纳入了83例因疑似CD转诊至胃肠病门诊的患者,并在诊断检查期间测量了fCal。回结肠镜检查+胶囊内镜/手术(n = 81)、回结肠镜检查+上消化道内镜检查(n = 1)以及回结肠镜检查(n = 1)作为CD存在和部位的金标准。

结果

共有40例患者被诊断为CD:小肠型13例,结肠型16例,回结肠型11例。小肠或结肠CD患者的fCal水平相当:中位数分别为890 mg/kg和830 mg/kg(p = 1.0)。以50 mg/kg为临界值,小肠和结肠CD的诊断敏感性分别为92%和94%,fCal的总体敏感性和特异性分别为95%和56%。在该队列中,fCal阴性预测值为92%可排除CD。

结论

这是第一项表明fCal在结肠和小肠CD中敏感性相同的研究。在疑似CD的患者中,fCal是排除该诊断并选择患者进行内镜检查的有效标志物。

相似文献

1
Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.粪便钙卫蛋白在影响小肠和结肠的克罗恩病中敏感性相同。
Scand J Gastroenterol. 2011 Jun;46(6):694-700. doi: 10.3109/00365521.2011.560680. Epub 2011 Apr 1.
2
Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.粪便钙卫蛋白和S100A12在预测通过无线胶囊内镜检测出的小肠克罗恩病方面效用较低。
Scand J Gastroenterol. 2012 Jul;47(7):778-84. doi: 10.3109/00365521.2012.677953. Epub 2012 Apr 23.
3
Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.粪便钙卫蛋白:疑似炎症性肠病患者在先前双向内镜检查结果为阴性时小肠胶囊内镜检查的筛选工具。
Scand J Gastroenterol. 2011 May;46(5):561-6. doi: 10.3109/00365521.2011.551835. Epub 2011 Jan 27.
4
Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.影响克罗恩病粪便钙卫蛋白值的内镜因素。
J Crohns Colitis. 2015 Dec;9(12):1113-9. doi: 10.1093/ecco-jcc/jjv150. Epub 2015 Sep 7.
5
Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.粪便钙卫蛋白可预测累及结肠的克罗恩病复发:一项前瞻性研究。
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):340-5. doi: 10.1097/MEG.0b013e32832bab49.
6
Ileoscopy reduces the need for small bowel imaging in suspected Crohn's disease.在疑似克罗恩病中,回肠镜检查减少了小肠成像的必要性。
Dan Med J. 2012 Sep;59(9):A4491.
7
Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.粪便免疫化学检测与粪便钙卫蛋白对克罗恩病黏膜愈合的预测作用
Inflamm Bowel Dis. 2016 May;22(5):1078-85. doi: 10.1097/MIB.0000000000000728.
8
Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.新型蝶呤可作为一种可靠的粪便标志物,其预测炎症性肠病患者内镜下疾病活动的准确性与钙卫蛋白相当。
Inflamm Bowel Dis. 2013 Apr;19(5):1043-52. doi: 10.1097/MIB.0b013e3182807577.
9
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.英夫利昔单抗应答者粪便钙卫蛋白预测克罗恩病复发:一项前瞻性研究。
Aliment Pharmacol Ther. 2011 Aug;34(4):462-9. doi: 10.1111/j.1365-2036.2011.04743.x. Epub 2011 Jun 14.
10
Impact of disease location on fecal calprotectin levels in Crohn's disease.疾病部位对克罗恩病粪便钙卫蛋白水平的影响。
Scand J Gastroenterol. 2015 Jul;50(7):841-7. doi: 10.3109/00365521.2015.1008035. Epub 2015 Jan 30.

引用本文的文献

1
Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease.粪便钙卫蛋白作为小肠克罗恩病的一种炎症生物标志物
Porto Biomed J. 2024 Aug 9;9(4):263. doi: 10.1097/j.pbj.0000000000000263. eCollection 2024 Jul-Aug.
2
Fecal Calprotectin in Patients with Crohn's Disease: A Study Based on the History of Bowel Resection and Location of Disease.克罗恩病患者的粪便钙卫蛋白:一项基于肠切除术史和疾病部位的研究
Diagnostics (Basel). 2024 Apr 22;14(8):854. doi: 10.3390/diagnostics14080854.
3
Calprotectin: two sides of the same coin.
钙卫蛋白:一枚硬币的两面。
Rheumatology (Oxford). 2024 Jan 4;63(1):26-33. doi: 10.1093/rheumatology/kead405.
4
Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases.粪便钙卫蛋白在炎症性肠病诊断和管理中的应用。
Clin Transl Gastroenterol. 2023 Sep 1;14(9):e00617. doi: 10.14309/ctg.0000000000000617.
5
Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn's disease.粪便钙卫蛋白在评估克罗恩病患者疾病活动度中的临床价值。
Front Physiol. 2023 Jun 1;14:1186665. doi: 10.3389/fphys.2023.1186665. eCollection 2023.
6
Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs.粪便钙卫蛋白在接受生物药物治疗的银屑病患者管理中的作用评估
Biomedicines. 2022 Nov 18;10(11):2968. doi: 10.3390/biomedicines10112968.
7
Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue?粪便钙卫蛋白用于小肠克罗恩病:这是一个临界值的问题吗?
Diagnostics (Basel). 2022 Sep 15;12(9):2226. doi: 10.3390/diagnostics12092226.
8
MicroRNA Expression and Intestinal Permeability in Children Living in a Slum Area of Bangladesh.孟加拉国贫民窟地区儿童的微小RNA表达与肠道通透性
Front Mol Biosci. 2021 Dec 8;8:765301. doi: 10.3389/fmolb.2021.765301. eCollection 2021.
9
Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease.肠超声评估妊娠中炎症性肠病患者的治疗反应。
Inflamm Bowel Dis. 2022 Jul 1;28(7):1045-1052. doi: 10.1093/ibd/izab216.
10
Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis.对猪进行实验性感染攻击后,结肠炎会导致粪便钙卫蛋白水平升高,但肠炎不会。
Porcine Health Manag. 2021 Aug 24;7(1):48. doi: 10.1186/s40813-021-00228-9.